MB
MPM BioImpact Portfolio holdings
AUM
$577M
This Quarter Return
+6.98%
1 Year Return
+8.33%
3 Year Return
+241.63%
5 Year Return
+127.38%
10 Year Return
–
AUM
$577M
AUM Growth
+$577M
(-0.78%)
Cap. Flow
-$12.6M
Cap. Flow
% of AUM
-2.19%
Top 10 Holdings %
Top 10 Hldgs %
45.32%
Holding
51
New
8
Increased
10
Reduced
20
Closed
7
Top Buys
| 1 |
Tarsus Pharmaceuticals
TARS
|
$13.8M |
| 2 |
Dyne Therapeutics
DYN
|
$13.8M |
| 3 |
Akebia Therapeutics
AKBA
|
$10.5M |
| 4 |
DBVT
DBV Technologies
DBVT
|
$9.65M |
| 5 |
Edgewise Therapeutics
EWTX
|
$8.07M |
Top Sells
| 1 |
Lantheus
LNTH
|
$22.7M |
| 2 |
United Therapeutics
UTHR
|
$18.2M |
| 3 |
ITOS
iTeos Therapeutics
ITOS
|
$10.4M |
| 4 |
Twist Bioscience
TWST
|
$10.3M |
| 5 |
Natera
NTRA
|
$9.82M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
51
United Therapeutics
UTHR
$18B
| – | – |
-58,907
| Closed | -$18.2M |
|